CooperVision’s leadership and commitment to transforming the trajectory of myopia in children was prominently showcased at the prestigious 60th International Myopia Conference (IMC) events in Changsha and Sanya, China. Research findings spanned the company’s comprehensive range of optical interventions, including MiSight® 1 day* soft contact lenses.
“Our dedication to advancing the science and practice of myopia management was on full display at IMC, as teams from CooperVision and our research partners around the globe debuted significant new studies,” said Elizabeth Lumb, BSc (Hons) MCOptom, FIACLE, FBCLA, Director of Global Professional Affairs, Myopia Management, CooperVision.
More than a dozen CooperVision authored and supported papers and posters were accepted to this year’s conference, including Myopia Control with MiSight® 1 day Dual Focus Lenses in Chinese Children (Arumugam B, et al).1 Interim results from an ongoing, double-masked, multi-center randomized clinical trial in China showed considerable efficacy of MiSight® 1 day in slowing myopia progression.1 The absolute treatment effects for both axial length and cycloplegic refractive error in children enrolled at ages 7 to 11 were even greater than those observed previously in a majority non-Asian cohort (Chamberlain, et al 2019).1,2
Additional CooperVision-supported papers and posters included an analysis of myopia control prescribing patterns in the U.S., Australia, and New Zealand, and research regarding the potential irradiance hazards of red-light therapy. Extended efficacy data for SightGlass Vision spectacle lenses with Diffusion Optics Technology™† advanced through a joint venture between CooperVision and EssilorLuxottica, was also presented.
The company also showcased multiple category experts through its digital platforms throughout the week, including LinkedIn. Researchers and program team members who have been instrumental in developing, sharing, and promoting invaluable myopia control and management science—work that is changing the lives of children worldwide—reflected on their work and its impact.3,4
Learn more at https://www.linkedin.com/company/coopervision.
For more details on the 2024 IMC, visit www.internationalmyopiaconference.org.
